| FIGO IGCS妇科恶性肿瘤分期及临床实践指南之八:滋养细胞疾病 |
|
| 作者：FIGO&IGC… 文章来源：广东省医学会妇科肿瘤分会翻译 点击数： 更新时间：2006-8-7 11:14:36 |
|
主要参考文献：
GTD的综合性综述
Gestational Trophoblastic Disease.Hancock BW,Newlands ES,Berkowitz RS,Chapman and Hall,1997.Available on web at:www.isstd.org.
定义
The Society of Gynecologic Oncologists’ Guidelines for referral to a gynaecologic oncologist:Rationale and benefits:Trophoblastic disease.Gynecol Oncol 2000;78:S13
hCG测定
Cole LA.Use of hCG tests for evaluating Trophoblastic Disease in Hancock et al as above,2002 and the ISSTD web site(www.isstd.org).
Cole LA.New perspectives in measuring human chorionic gonadotropin levels for measuring and monitoring Trophoblastic Disease.J Reprod. Med.39:193-200,194.
Cole LA.Phantom hCG and Phantom Choriocarcinoma.Gynecol Oncol.71:325-329,1998
影像
Kohorn EI,McCarthy SM,Taylor KJW:Nonmetastatic Gestational Trophoblastic Neoplasia.The Role of Ultrasonography and Magnetic Resonance Imaging.J Reprod Med.43:14-20,1998
分类和分期
Ngan HYS,Benedet JL,Jones III HW,Bender HG,Pecorelli S.FIGO staging and risk factor scoring for trophoblastic neoplasia.Int J Gynecol Obstet.7:285-287,2002
Kohorn EI.Staging and assessing trophoblastic tumors,a possible solution to an intractable problem.J Reprod Med.43:33-36,1998
Kohorn EI.Evaluation or the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.Gynecol Oncol.48:139-147, 1993
Kohorn EI. The trophoblastic tower of Babel classifications systems for metastatic gestational trophoblastic neoplasia.Gynecol Oncol .280-288, 1995
Hancock BW, Welch EM,Gillespie AM,et al.A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease.Int J Gynecol Cancer.10:318-322, 2000.
病理
Paradinas FJ.Pathology in gestational trophoblastic disease.Hancock BW,Newlands ES,Berkowitz RS.Chapman and Hall,1997,43-76.
Genest DR.Partial hydatidiform mole:clinicopathological features,differential diagnosis.Ploidy and molecular studies and gold standards for diagnosis.Int J Gynecol Path.20:315-322,2001.
有趣的论文
NewlandsES,Bagshawe KD,Begent RHJ,Rustin GJS,Holden L.Results with the EMA/CO (etoposide,methotrexate,actinomycin D,cyclophosphamide,vincristine) regimen in high risk gestational trophoblastic tumors, 1979 to 1989.Br J Obstet Gynaecol.98:550-557,1991
Kohorn EI.Decision making for chemotherapy administration in patients with low-risk gestational trophoblastic neoplasia.Int J Gynecol Cancer.6:279-285,1996
Rustin GJS,Newlands ES,Begent RHJ,Dent J,Bagshawe KD.Weekly alternating etoposide, methotrexate,and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.J Clin Oncol.7:900-903,1989
Kohorn EI.Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associate with dose scheduling or chemotherapy resistance? Gynecol Oncol.85:36-39,2002.
上一页 [1] [2] [3] [4] [5] [6] [7] [8] 下一页 |
|
本站声明：凡从本站转载文章,必须标明来源为“转载自中国妇产科网www.china-obgyn.net”
文章录入：gongxm 责任编辑：gongxm |
|
上一篇文章： FIGO&IGCS：卵巢癌
下一篇文章： FIGO&IGCS：乳腺癌 |
| 【字体：小 大】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口】 |
用户登录 
新用户注册 
网友评论：（只显示最新10条。评论内容只代表网友观点，与本站立场无关！）
